Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Old API Wind-down Ltd - Ordinary Shares ARLZQ

"Old API Wind-down Ltd, formerly Aralez Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in the acquisition, development, and commercialization of products primarily in cardiovascular, pain management and other specialty areas. Its key products include Fiorinal, Proferrin, Fibricor, Uracyst and Neovisc, Cambia and other marketed products. The company currently operates in two geographical markets, the United States and Canada. The firm generates most of its reven


OTCPK:ARLZQ - Post by User

Comment by kuatoliveson Oct 26, 2016 10:18pm
106 Views
Post# 25390760

RE:RE:RE:RE:RE:RE:RE:RE:TRX

RE:RE:RE:RE:RE:RE:RE:RE:TRXYou can wait for Yosprala numbers to come in, and that's a valid strategy, but you risk missing on a gap-up based on those numbers or other business development etc etc. The bulk of a stock's increase for the year happens on 2 or 3 trading days. ARLZ could also announce tomorrow they've been purchased for $10/share for a cash deal thus ending the entire TRX/POZN/ARLZ story. Nobody knows.

I've got a practice margin account that I play around with, but it's always a losing proposition. My only winners are buy and hold investments in my real accounts.  And if you invest in what you think are sound management teams, you tend to make money over time. I think I'm still up like 40% over 2 years or something with TRX/ARLZ which is not the 400% peak I had, but even at these gutter levels I'm still averaging more than most professional fund managers. I never invested in any of the Dalsin pump and dumps because I thought the guy was a scumbag. That instinct saved me a bunch of money.

I have to conclude the market is treating ARLZ irrationally. I can't for one instant think a bunch of bozo traders have the inside track of Yosprala adoption when Aralez probably doesn't even know yet. If you project 150M revenue for 2017 with relative profitability, trading at 2x is a super big bargain. I'm still accumulating, and let me tell you, I sleep WAY better now with Yosprala approval and the other business development in the bank @4.50 then I did @6.50 with all the uncertainty.  I'm also content to wait until Q4 numbers are annouced in 2017 to re-visit this investment.  We just don't know anything until then.  







<< Previous
Bullboard Posts
Next >>